Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by LaserStock29on Jul 12, 2020 11:37am
190 Views
Post# 31257377

RE:RE:RE:RE:RE:RE:What would possibly be the strategy for SILENCE?

RE:RE:RE:RE:RE:RE:What would possibly be the strategy for SILENCE?Read the nr and read fda page. May 19 to July 19 is 60 days to reply officially to said company on fast track application. We became eligible post receipt of IND this is absolutely unabated immutable FACT.
realty wrote: Laserstock29, I agree with your thoughts completely.  Why is July 19th the deadline for information though?  Is there a requirement for them to disclose something by then?  In their last news release it appears that they plan on not releasing any news until December 31, 2020.  It appears that they want to take advantage of a loophole in the law that gives them a free pass.  I dont understand why the company does not want to release any news on the patients from the first clinical trial or the second clinical trial or anything on the studies being completed on brain and lung cancer.  The lack of news on the clinicals naturally makes it look like they are hiding something.  One can only speculate what is going on behind the scenes.  Maybe they dont want to be bought up by a big Pharma Company if the new is good.  If its bad, well the whole company is based on these studies now and failure could destroy them.  Beats me, but this is very frustrating to say the least.  Realty


Bullboard Posts